NO320644B1 - Bioaktivt hydrolysat av myseprotein, fremgangsmate for fremstilling derav, og produkter derfra. - Google Patents
Bioaktivt hydrolysat av myseprotein, fremgangsmate for fremstilling derav, og produkter derfra. Download PDFInfo
- Publication number
- NO320644B1 NO320644B1 NO20006305A NO20006305A NO320644B1 NO 320644 B1 NO320644 B1 NO 320644B1 NO 20006305 A NO20006305 A NO 20006305A NO 20006305 A NO20006305 A NO 20006305A NO 320644 B1 NO320644 B1 NO 320644B1
- Authority
- NO
- Norway
- Prior art keywords
- accordance
- hydrolysis
- product
- enzyme
- whey protein
- Prior art date
Links
- 230000000975 bioactive effect Effects 0.000 title claims abstract description 34
- 238000000034 method Methods 0.000 title claims abstract description 29
- 108010046377 Whey Proteins Proteins 0.000 title claims description 54
- 235000021119 whey protein Nutrition 0.000 title claims description 50
- 102000007544 Whey Proteins Human genes 0.000 title claims description 41
- 230000008569 process Effects 0.000 title description 3
- 102000004190 Enzymes Human genes 0.000 claims abstract description 62
- 108090000790 Enzymes Proteins 0.000 claims abstract description 61
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 59
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 58
- 230000007062 hydrolysis Effects 0.000 claims abstract description 56
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 47
- 229940088598 enzyme Drugs 0.000 claims description 61
- 239000000758 substrate Substances 0.000 claims description 30
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 27
- 239000008101 lactose Substances 0.000 claims description 27
- 239000003531 protein hydrolysate Substances 0.000 claims description 18
- 239000002245 particle Substances 0.000 claims description 15
- 102100026189 Beta-galactosidase Human genes 0.000 claims description 14
- 108010005774 beta-Galactosidase Proteins 0.000 claims description 14
- 108091005804 Peptidases Proteins 0.000 claims description 13
- 229940116108 lactase Drugs 0.000 claims description 12
- 108010059881 Lactase Proteins 0.000 claims description 11
- 102000035195 Peptidases Human genes 0.000 claims description 11
- 108010009355 microbial metalloproteinases Proteins 0.000 claims description 11
- 239000004365 Protease Substances 0.000 claims description 9
- 235000019419 proteases Nutrition 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 7
- 235000013305 food Nutrition 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 5
- 235000009508 confectionery Nutrition 0.000 claims description 5
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 5
- 230000003301 hydrolyzing effect Effects 0.000 claims description 5
- 101001091385 Homo sapiens Kallikrein-6 Proteins 0.000 claims description 4
- 102100034866 Kallikrein-6 Human genes 0.000 claims description 4
- 101710180012 Protease 7 Proteins 0.000 claims description 4
- 239000005862 Whey Substances 0.000 claims description 4
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 4
- 235000019833 protease Nutrition 0.000 claims description 4
- 108091005658 Basic proteases Proteins 0.000 claims description 3
- 229920001661 Chitosan Polymers 0.000 claims description 3
- 108091005507 Neutral proteases Proteins 0.000 claims description 3
- 102000035092 Neutral proteases Human genes 0.000 claims description 3
- 229920001525 carrageenan Polymers 0.000 claims description 3
- 239000000679 carrageenan Substances 0.000 claims description 3
- 235000010418 carrageenan Nutrition 0.000 claims description 3
- 229940113118 carrageenan Drugs 0.000 claims description 3
- 229930182830 galactose Natural products 0.000 claims description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 3
- 108090000145 Bacillolysin Proteins 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 239000012876 carrier material Substances 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 2
- 230000002378 acidificating effect Effects 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 abstract description 20
- 108090000623 proteins and genes Proteins 0.000 abstract description 20
- 230000035488 systolic blood pressure Effects 0.000 abstract description 4
- 230000036961 partial effect Effects 0.000 abstract description 2
- 235000019636 bitter flavor Nutrition 0.000 abstract 2
- 239000000413 hydrolysate Substances 0.000 abstract 2
- 230000000694 effects Effects 0.000 description 24
- 239000000047 product Substances 0.000 description 24
- 101710086378 Bradykinin-potentiating and C-type natriuretic peptides Proteins 0.000 description 22
- 239000005541 ACE inhibitor Substances 0.000 description 21
- 101710129690 Angiotensin-converting enzyme inhibitor Proteins 0.000 description 21
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 21
- 235000019658 bitter taste Nutrition 0.000 description 19
- 235000018102 proteins Nutrition 0.000 description 19
- 235000019640 taste Nutrition 0.000 description 16
- 239000000203 mixture Substances 0.000 description 14
- 241000700159 Rattus Species 0.000 description 12
- 239000000843 powder Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 10
- 230000007065 protein hydrolysis Effects 0.000 description 9
- 102000014171 Milk Proteins Human genes 0.000 description 8
- 108010011756 Milk Proteins Proteins 0.000 description 8
- 235000021239 milk protein Nutrition 0.000 description 8
- 238000011282 treatment Methods 0.000 description 7
- 102000011632 Caseins Human genes 0.000 description 6
- 108010076119 Caseins Proteins 0.000 description 6
- 239000005018 casein Substances 0.000 description 6
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 6
- 235000021240 caseins Nutrition 0.000 description 6
- 230000009849 deactivation Effects 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 108010009736 Protein Hydrolysates Proteins 0.000 description 5
- 239000013068 control sample Substances 0.000 description 5
- 239000012467 final product Substances 0.000 description 5
- 239000012466 permeate Substances 0.000 description 5
- 102100030988 Angiotensin-converting enzyme Human genes 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000000108 ultra-filtration Methods 0.000 description 4
- ZDLZKMDMBBMJLI-FDMDGMSGSA-N 2-[[2-[[(2s)-2-[[(e)-3-(furan-2-yl)prop-2-enoyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]acetic acid Chemical compound C([C@@H](C(=O)NCC(=O)NCC(=O)O)NC(=O)\C=C\C=1OC=CC=1)C1=CC=CC=C1 ZDLZKMDMBBMJLI-FDMDGMSGSA-N 0.000 description 3
- 108010048632 2-furanacryloyl-phenylalanyl-glycyl-glycine Proteins 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 240000006439 Aspergillus oryzae Species 0.000 description 3
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 3
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000003276 anti-hypertensive effect Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000002779 inactivation Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000019629 palatability Nutrition 0.000 description 3
- 239000012465 retentate Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 108091005508 Acid proteases Proteins 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 101000984728 Chiropsoides quadrigatus Angiotensin-converting enzyme inhibitory peptide Proteins 0.000 description 2
- 206010013911 Dysgeusia Diseases 0.000 description 2
- 239000005905 Hydrolysed protein Substances 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 239000005417 food ingredient Substances 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- -1 lactose Chemical class 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000004007 reversed phase HPLC Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 235000008939 whole milk Nutrition 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000001860 Eye Infections Diseases 0.000 description 1
- 101000993347 Gallus gallus Ciliary neurotrophic factor Proteins 0.000 description 1
- 101800004361 Lactoferricin-B Proteins 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 238000010793 Steam injection (oil industry) Methods 0.000 description 1
- 244000290333 Vanilla fragrans Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940009289 bifidobacterium lactis Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 1
- 229960000830 captopril Drugs 0.000 description 1
- 229940021722 caseins Drugs 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 208000011323 eye infectious disease Diseases 0.000 description 1
- 239000013020 final formulation Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- CFFMZOZGXDAXHP-HOKBLYKWSA-N lactoferricin Chemical compound C([C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CSSC[C@@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CO)C(=O)N[C@H](C(N[C@H](C(=O)N1)[C@@H](C)O)=O)[C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CFFMZOZGXDAXHP-HOKBLYKWSA-N 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 235000019520 non-alcoholic beverage Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000021262 sour milk Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000011699 spontaneously hypertensive rat Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
- A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ33071098 | 1998-06-17 | ||
| PCT/NZ1999/000084 WO1999065326A1 (fr) | 1998-06-17 | 1999-06-14 | Hydrolysat de proteine bioactive du petit-lait |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20006305D0 NO20006305D0 (no) | 2000-12-12 |
| NO20006305L NO20006305L (no) | 2001-02-14 |
| NO320644B1 true NO320644B1 (no) | 2006-01-09 |
Family
ID=19926776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20006305A NO320644B1 (no) | 1998-06-17 | 2000-12-12 | Bioaktivt hydrolysat av myseprotein, fremgangsmate for fremstilling derav, og produkter derfra. |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US6919314B1 (fr) |
| EP (1) | EP1087668B1 (fr) |
| AT (1) | ATE275831T1 (fr) |
| AU (1) | AU761477B2 (fr) |
| DE (1) | DE69920219T2 (fr) |
| DK (1) | DK1087668T3 (fr) |
| MY (1) | MY126517A (fr) |
| NO (1) | NO320644B1 (fr) |
| NZ (1) | NZ508867A (fr) |
| PE (1) | PE20000717A1 (fr) |
| TW (1) | TWI225490B (fr) |
| WO (1) | WO1999065326A1 (fr) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1087668B1 (fr) * | 1998-06-17 | 2004-09-15 | New Zealand Dairy Board | Hydrolysat de proteine bioactive du petit-lait |
| US6998259B1 (en) | 1999-05-20 | 2006-02-14 | Davisco Foods International | Enzymatic treatment of whey proteins for the production of antihypertensive peptides and the resulting products |
| US6630320B1 (en) | 2000-05-08 | 2003-10-07 | Devisco Foods International, Inc. | Treatment of hypertension in mammals with hydrolyzed whey proteins |
| NZ506866A (en) * | 2000-09-11 | 2003-05-30 | New Zealand Dairy Board | Bioactive whey protein hydrolysate free of bitter flavours wherein the enzyme used is a heat labile protease |
| GB0029777D0 (en) * | 2000-12-06 | 2001-01-17 | Regen Therapeutics Plc | Peptides |
| WO2002069734A1 (fr) * | 2001-03-05 | 2002-09-12 | Council Of Scientific And Industrial Research | Procede de preparation d'hydrolysat proteique a partir des proteines du lait |
| FR2827480B1 (fr) | 2001-07-17 | 2003-09-19 | Cie Laitiere Europeenne | Lactoserum modifie, procede de preparation, utilisation et produit de panification comprenant le lactoserum modifie |
| WO2003059083A1 (fr) * | 2002-01-21 | 2003-07-24 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Hydrolysats de proteines lactoseriques et fractions peptidiques de proteine lactoserique a effet bio-actif obtenus par hydrolyse avec des proteases |
| EP1359157A1 (fr) | 2002-04-29 | 2003-11-05 | Société des Produits Nestlé S.A. | Agent d'inhibition de métalloproteinase |
| EP1575375A1 (fr) | 2002-12-24 | 2005-09-21 | Her Majesty The Queen in Right of Canada, as represented by The Minister of Agriculture and Agri-Food Canada | Peptides inhibiteurs de l'enzyme de conversion de l'angiotensine (ace) issus de substances vegetales |
| US7399496B2 (en) * | 2003-02-07 | 2008-07-15 | Glanbia Nutritionals (Ireland) Limited | Hydrolyzed whey protein compositions |
| ES2277571B1 (es) * | 2003-05-21 | 2009-05-01 | Grupo Leche Pascual S.A. | Procedimiento para producir un peptido bioactivo utilizando cepas de enterococcus faecalis. |
| DE10331202A1 (de) | 2003-07-10 | 2005-03-31 | S.K. Enterprise Gmbh | Verwendung von Molkenpermeat zur Behandlung des Metabolischen Syndroms |
| US20050265946A1 (en) * | 2004-05-28 | 2005-12-01 | Kao Corporation | Elastase inhibitor |
| WO2006012536A2 (fr) | 2004-07-22 | 2006-02-02 | Ritter Andrew J | Procedes et compositions pour le traitement de l'intolerance au lactose |
| CN100415768C (zh) * | 2004-11-29 | 2008-09-03 | 中国农业大学 | 乳清蛋白酶法生产血管紧张素转化酶（ace）抑制肽的方法 |
| GB2421890A (en) * | 2004-12-09 | 2006-07-12 | Biocatalysts Ltd | Method for producing a palatability enhancer for a foodstuff |
| US20070020744A1 (en) * | 2005-07-15 | 2007-01-25 | Amano Enzyme Usa Co., Ltd | Enzyme compositions that enhance the flavor of food and beverages |
| US20070082056A1 (en) * | 2005-10-12 | 2007-04-12 | Sawhill James W | Antibiotic peptide product |
| US8101377B2 (en) * | 2006-01-04 | 2012-01-24 | Leprino Foods Company | Protein hydrolysates and method of making |
| US7875303B2 (en) * | 2006-03-31 | 2011-01-25 | Kraft Foods Global Brands Llc | Protein system and food products including same |
| JP5306188B2 (ja) * | 2006-06-15 | 2013-10-02 | マレー・ゴールバーン・コー−オペラティヴ・カンパニー・リミテッド | 筋肉回復を高めるための乳清タンパク質および加水分解物を含む調製物 |
| DE102006036285A1 (de) * | 2006-08-03 | 2008-02-07 | "S.U.K." Beteiligungs Gmbh | Fraktionen aus Molkepermeat und deren Verwendung zur Prävention und Therapie des Typ-2 Diabetes und des Metabolischen Syndroms |
| EP1967524A1 (fr) * | 2007-03-06 | 2008-09-10 | Friesland Brands B.V. | Procédés pour la fabrication de peptides inhibiteurs de l'enzyme de conversion de l'angiotensine du lactosérum et peptides ainsi obtenus |
| MY158225A (en) | 2007-11-07 | 2016-09-15 | Mjn Us Holdings Llc | Method for decreasing bitterness and improving taste of protein-free and hydrolyzed infant formulas |
| US20110223248A1 (en) * | 2007-12-12 | 2011-09-15 | Ritter Pharmaceuticals, Inc. | Methods and compositions for treating lactose intolerance |
| NZ586677A (en) | 2008-03-19 | 2012-06-29 | Wisconsin Alumni Res Found | Production of protein-polysaccharide conjugates |
| CN102014947B (zh) * | 2008-03-26 | 2016-10-19 | 格兰比亚营养物(爱尔兰)有限公司 | 富含亮氨酸的肽组合物和分离方法 |
| DE102008032828A1 (de) | 2008-07-02 | 2010-01-07 | Technische Universität Dresden | Tryptophanhaltige Peptide aus alpha-Lactalbumin mit blutdrucksenkender und vasoprotektiver Wirkung für biofunktionelle Lebensmittel |
| US20100055247A1 (en) * | 2008-08-29 | 2010-03-04 | Tirrito Salvatore J | Nutritional Compositions for Athletes |
| JP5749419B2 (ja) * | 2008-12-24 | 2015-07-15 | 雪印メグミルク株式会社 | 筋肉増強剤 |
| CA2984935C (fr) * | 2009-02-24 | 2021-01-12 | Ritter Pharmaceuticals, Inc. | Formulations prebiotiques et methodes d'utilisation |
| EP2405918B2 (fr) * | 2009-03-13 | 2020-09-02 | The Regents of The University of California | Oligosaccharides prébiotiques |
| JP5782021B2 (ja) | 2009-04-02 | 2015-09-24 | ノボザイムス アクティーゼルスカブ | 乳由来タンパク質加水分解物の製法 |
| EP2253324A1 (fr) | 2009-04-30 | 2010-11-24 | Consejo Superior De Investigaciones Cientificas | Utilisation d'un peptide dérivé de caséine et compositions associées en tant qu'anti-hypertensive |
| PT105073A (pt) | 2010-04-26 | 2011-10-26 | Consejo Superior Investigacion | Processo de obtenção de extractos peptídicos bioactivos através da hidrólise de proteínas de soro de leite com enzimas de cynara cardunculus, referidos extractos e respectivas utilizações |
| EP3202406A1 (fr) * | 2010-04-28 | 2017-08-09 | Ritter Pharmaceuticals, Inc. | Formulations prébiotiques et méthodes d'utilisation |
| FI123201B (fi) | 2010-10-29 | 2012-12-14 | Valio Oy | Maitopohjainen tuote ja valmistusmenetelmä |
| US20150150275A1 (en) * | 2013-12-03 | 2015-06-04 | The United States Of America, As Represented By The Secretary Of Agriculture | Methods For Processing Acid Whey |
| US20190069589A1 (en) | 2015-10-01 | 2019-03-07 | Frieslandcampina Nederland B.V. | Liquid nutritional composition comprising micellar casein and hydrolysed whey protein |
| JPWO2017086303A1 (ja) * | 2015-11-16 | 2018-09-20 | キリン株式会社 | ペプチド組成物およびその製造方法 |
| US10820618B2 (en) | 2015-12-18 | 2020-11-03 | Societe Des Produits Nestle S.A. | Heat sterilized high protein compositions with hydrolyzed protein from a continuous process with at least one endopeptidase |
| US20200305445A1 (en) | 2017-10-26 | 2020-10-01 | Basf Se | Protein hydrolysates as emulsifier for baked goods |
| WO2020239998A1 (fr) * | 2019-05-29 | 2020-12-03 | Arla Foods Amba | Hydrolysats de protéines de lactosérum largement hydrolysés, de goût agréable |
| CN112010947B (zh) * | 2020-09-10 | 2022-05-24 | 中新国际联合研究院 | 一种具有血管紧张素转换酶抑制活性的环十六肽及其制备方法与应用 |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US592193A (en) * | 1897-10-19 | Sylvania | ||
| US3843621A (en) * | 1971-08-19 | 1974-10-22 | Merck & Co Inc | Process for preparing leucyl-leucyl-valyl-henylalanyl methyl ester |
| US3970520A (en) | 1973-09-17 | 1976-07-20 | General Foods Corporation | Nutritionally improved foodstuffs |
| FR2309154A1 (fr) | 1975-03-11 | 1976-11-26 | Bel La Vache Qui Rit Fromage | Procede de valorisation du lactoserum |
| US4358464A (en) | 1977-08-02 | 1982-11-09 | Superior Dairy, Inc. | Process for converting sour whey into sweet whey and product |
| CH636248A5 (fr) * | 1979-03-09 | 1983-05-31 | Nestle Sa | Procede de preparation d'un hydrolysat de proteines purifie. |
| EP0065663A1 (fr) * | 1981-05-11 | 1982-12-01 | Miles Laboratories, Inc. | Méthode de préparation d'un hydrolysat de protéines à partir du petit-lait |
| US4479975A (en) | 1983-01-13 | 1984-10-30 | General Foods Corporation | Fruit flavored beverages |
| US4954443A (en) * | 1984-12-27 | 1990-09-04 | The Nisshin Oil Mills, Ltd. | Method of immobilizing biochemically active substance with xanthan gum |
| EP0210204B1 (fr) | 1985-01-18 | 1988-12-07 | Kailash Kumar Dr. Prof. Gauri | Hydrolysats de proteine, leur procede de production et medicaments les contenant |
| SE459140B (sv) * | 1986-11-25 | 1989-06-12 | Albuglobe Ab | Hydrolys av vassleprotein foer att underlaetta avskiljning av fett daerifraan |
| US4853246A (en) * | 1987-12-01 | 1989-08-01 | Tetra Pak Inc. | Sweetened high protein milk product and process for producing same |
| EP0321603A1 (fr) | 1987-12-23 | 1989-06-28 | Societe Des Produits Nestle S.A. | Procédé de préparation d'un hydrolysat de protéines de lactosérum et d'un aliment hypoallergéniques |
| EP0322589B1 (fr) | 1987-12-23 | 1993-01-20 | Societe Des Produits Nestle S.A. | Procédé de préparation d'un hydrolysat de protéines de lactosérum et d'un aliment hypoallergéniques |
| FR2634104B1 (fr) | 1988-07-18 | 1991-10-18 | Union Coop Agricole | Hydrolysat partiel de proteines de lactoserum, procede enzymatique de preparation de cet hydrolysat, et aliment lacte dietetique hypoallergenique le contenant |
| DK0421309T4 (da) | 1989-10-02 | 2003-04-22 | Associated British Foods Plc | Proteinhydrolysater |
| US5866357A (en) | 1990-03-09 | 1999-02-02 | Novo Nordisk A/S | Method for hydrolyzing proteins with gluyasp specific protease |
| JP2818056B2 (ja) * | 1990-09-07 | 1998-10-30 | 森永乳業株式会社 | 抗菌性ペプチドおよび抗菌剤 |
| US5093137A (en) * | 1990-10-17 | 1992-03-03 | Shazer Jr William H | Reduced calorie frozen dairy desserts and processes for producing them |
| JP3091772B2 (ja) * | 1991-03-12 | 2000-09-25 | カルピス株式会社 | アンジオテンシン変換酵素阻害ペプチド組成物 |
| JP3149199B2 (ja) | 1991-03-12 | 2001-03-26 | カルピス株式会社 | アンジオテンシン変換酵素阻害ペプチド |
| RU2084172C1 (ru) | 1991-05-31 | 1997-07-20 | Данмарк Протеин А/С | Способ получения гидролизата белка молочной сыворотки |
| EP0604467A1 (fr) | 1991-08-30 | 1994-07-06 | Teagasc, The Agriculture And Food Development Authority | Hydrolysat de proteines lactoseriques hypoallergeniques |
| JP3092870B2 (ja) | 1991-10-18 | 2000-09-25 | 雪印乳業株式会社 | 牛乳ホエータンパク加水分解物の製造方法 |
| DK71292D0 (fr) | 1992-05-27 | 1992-05-27 | Novo Nordisk As | |
| NZ258207A (en) | 1992-11-30 | 1996-02-27 | Morinaga Milk Industry Co Ltd | Whey protein with low phosphorus content |
| JPH06345664A (ja) | 1993-06-11 | 1994-12-20 | Takako Tomita | 新規な血圧上昇抑制用組成物 |
| US5405637A (en) | 1993-06-30 | 1995-04-11 | Bristol-Myers Squibb Company | Milk protein partial hydrolysate and infant formula containing same |
| JP3327500B2 (ja) | 1994-08-17 | 2002-09-24 | 森永乳業株式会社 | 乳糖分解甘性ホエー濃縮物及びその製造法 |
| JP3398490B2 (ja) | 1994-09-30 | 2003-04-21 | 雪印乳業株式会社 | ホエータンパク質ペプチド組成物及びその製造法 |
| EP0799577B1 (fr) | 1994-10-14 | 2001-02-14 | Morinaga Milk Industry Co., Ltd. | Melange de peptides et leurs produits |
| JP3542093B2 (ja) * | 1995-06-01 | 2004-07-14 | オーム乳業株式会社 | 苦味が少なく且つ低アレルゲン性の乳組成物とその製造方法 |
| KR100437984B1 (ko) * | 1995-06-30 | 2004-09-18 | 아를라 푸즈 에이엠비에이 | 펩티드혼합물의제조방법 |
| JPH1033115A (ja) | 1996-07-24 | 1998-02-10 | Nouchikusangiyou Shinko Jigyodan | ホエー飲料とその製造法 |
| US5837312A (en) | 1996-09-20 | 1998-11-17 | Abbott Laboratories | Debittered protein product having improved antigenicity and method for manufacture |
| JP2001516009A (ja) | 1997-07-17 | 2001-09-25 | ルードヴィッヒ インスティテュート フォー キャンサー リサーチ | ガン関連核酸及びポリペプチド |
| EP1087668B1 (fr) | 1998-06-17 | 2004-09-15 | New Zealand Dairy Board | Hydrolysat de proteine bioactive du petit-lait |
| MY129566A (en) | 1999-01-19 | 2007-04-30 | Nestle Sa | A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance |
| US6630320B1 (en) * | 2000-05-08 | 2003-10-07 | Devisco Foods International, Inc. | Treatment of hypertension in mammals with hydrolyzed whey proteins |
| US6551636B2 (en) * | 1999-07-23 | 2003-04-22 | Novozymes A/S | Modification of foaming properties of proteins |
| CA2415688A1 (fr) | 2000-05-08 | 2001-11-15 | Anand Rao | Traitement enzymatique des proteines de lactoserum permettant d'obtenir des peptides anti-hypertension, produits obtenus et traitement de l'hypertension chez les mammiferes |
-
1999
- 1999-06-14 EP EP99928257A patent/EP1087668B1/fr not_active Expired - Lifetime
- 1999-06-14 NZ NZ508867A patent/NZ508867A/en unknown
- 1999-06-14 AU AU45359/99A patent/AU761477B2/en not_active Ceased
- 1999-06-14 WO PCT/NZ1999/000084 patent/WO1999065326A1/fr active IP Right Grant
- 1999-06-14 DK DK99928257T patent/DK1087668T3/da active
- 1999-06-14 DE DE69920219T patent/DE69920219T2/de not_active Expired - Lifetime
- 1999-06-14 US US09/720,041 patent/US6919314B1/en not_active Expired - Fee Related
- 1999-06-14 AT AT99928257T patent/ATE275831T1/de not_active IP Right Cessation
- 1999-06-16 PE PE1999000532A patent/PE20000717A1/es not_active Application Discontinuation
- 1999-06-16 MY MYPI99002487A patent/MY126517A/en unknown
- 1999-06-24 TW TW088110663A patent/TWI225490B/zh not_active IP Right Cessation
-
2000
- 2000-12-12 NO NO20006305A patent/NO320644B1/no unknown
-
2001
- 2001-09-11 US US10/070,406 patent/US7148034B2/en not_active Expired - Fee Related
-
2005
- 2005-03-17 US US11/083,662 patent/US20050164340A1/en not_active Abandoned
-
2009
- 2009-02-23 US US12/391,220 patent/US20090258387A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1087668B1 (fr) | 2004-09-15 |
| AU4535999A (en) | 2000-01-05 |
| NO20006305L (no) | 2001-02-14 |
| NZ508867A (en) | 2003-11-28 |
| ATE275831T1 (de) | 2004-10-15 |
| DK1087668T3 (da) | 2005-01-24 |
| MY126517A (en) | 2006-10-31 |
| US6919314B1 (en) | 2005-07-19 |
| DE69920219D1 (de) | 2004-10-21 |
| AU761477B2 (en) | 2003-06-05 |
| US20090258387A1 (en) | 2009-10-15 |
| EP1087668A1 (fr) | 2001-04-04 |
| PE20000717A1 (es) | 2000-08-04 |
| TWI225490B (en) | 2004-12-21 |
| WO1999065326A1 (fr) | 1999-12-23 |
| US20050164340A1 (en) | 2005-07-28 |
| NO20006305D0 (no) | 2000-12-12 |
| US20040086958A1 (en) | 2004-05-06 |
| US7148034B2 (en) | 2006-12-12 |
| DE69920219T2 (de) | 2005-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO320644B1 (no) | Bioaktivt hydrolysat av myseprotein, fremgangsmate for fremstilling derav, og produkter derfra. | |
| EP1317186B1 (fr) | Hydrolysat proteique bioactif ameliore de lactoserum | |
| AU2002325890B2 (en) | Process for the hydrolysis of milk proteins | |
| AU2001290376A1 (en) | Improved bioactive whey protein hydrolysate | |
| JP5745402B2 (ja) | α−ラクトアルブミン由来のトリプトファン含有ペプチドを含有する乳漿タンパク質加水分解物およびその使用 | |
| EP1874140B1 (fr) | Peptides presentant un effet benefique pour la sante et compositions contenant ces peptides | |
| AU2002325890A1 (en) | Process for the hydrolysis of milk proteins | |
| WO2011108692A1 (fr) | Agent pour la prévention de l'atrophie musculaire | |
| JP2986764B2 (ja) | 苦味の少ないアミノ酸組成が人乳に近い高フィッシャー比ペプチドの調製方法 | |
| AU2003204321B2 (en) | Bioactive Whey Protein Hydrolysate | |
| WO2011046101A1 (fr) | Suppresseur d'accumulation des graisses | |
| AU2022353630A1 (en) | Method for producing peptide |